Star Imaging and Path Lab Limited share price
BSE: STARIMAGIN
Key numbers
- Market cap
- ₹ 135 Cr
- Current price
- ₹ 77.70
- 52-week high / low
- ₹ 152 / 46
- Stock P/E
- 7.0
- Book value
- ₹ 66.8
- Dividend yield
- 0.00%
- ROCE
- 26.1%
- ROE
- 23.5%
- Debt to equity
- 0.18
- Sales growth (3 yrs)
- 14.7%
- Profit growth (3 yrs)
- 221.5%
- 1-year return
- -41.2%
About Star Imaging and Path Lab Limited
Star Imaging and Path Lab Limited operates as a diagnostic testing network and provides diagnostic imaging services and clinical laboratory tests in India. It offers diagnostic and radiology services, which includes X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, 4D and 5D ultrasounds, bone mineral densitometry, mammography, and orthopantomogram, surgical/anatomic pathology; pathology services, includes hematology, polymerase chain reaction, clinical pathology, histopathology, cytopathology, treadmill stress test, echocardiogram, microbiology, serology, cytology, immunology and bio chemistry, electrocardiogram, and immunology, holter monitoring, electroencephalogram, visual evoked potential, nerve conduction velocity, brainstem evoked response audiometry, electromyography, sleep study, pulmonary function test, fibro scan, and uroflowmetry; and other specialized testing services. It also provides Dexa scan, colour doppler, neurology, fetal echocardiography, dental imaging, CT Angiography, HMPV Rt-PCR test, Covid-19 test, and other tests, health packages as well as online reports access services. The company operates a tele-radiology hub. Star Imaging…
Peers in Diagnostics & Research
Data for information only, not investment advice. Prices end of day.